Evidence map›Paper›PMID 36773219›Full record

ArticleForensic toxicology2023

Proteomic identification and quantification of Clostridium perfringens enterotoxin using a stable isotope-labelled peptide via liquid chromatography-tandem mass spectrometry.

Hiroshi Koike, Maki Kanda, Souichi Yoshikawa, Hiroshi Hayashi, Yoko Matsushima, Yumi Ohba, Momoka Hayashi, Chieko Nagano, Kenji Otsuka, Junichi Kamiie and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Forensic toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Hiroshi KoikeDepartment of Food Safety, Tokyo Metropolitan Institute of Public Health, 3-24-1, Hyakunin-Cho, Shinjuku-Ku, Tokyo, 169-0073, Japan. Hiroshi_2_Koike@member.metro.tokyo.jp.ORCID 0000-0002-9842-632X
Maki KandaDepartment of Food Safety, Tokyo Metropolitan Institute of Public Health, 3-24-1, Hyakunin-Cho, Shinjuku-Ku, Tokyo, 169-0073, Japan.
Souichi YoshikawaDepartment of Food Safety, Tokyo Metropolitan Institute of Public Health, 3-24-1, Hyakunin-Cho, Shinjuku-Ku, Tokyo, 169-0073, Japan.
Hiroshi HayashiDepartment of Food Safety, Tokyo Metropolitan Institute of Public Health, 3-24-1, Hyakunin-Cho, Shinjuku-Ku, Tokyo, 169-0073, Japan.
Yoko MatsushimaDepartment of Food Safety, Tokyo Metropolitan Institute of Public Health, 3-24-1, Hyakunin-Cho, Shinjuku-Ku, Tokyo, 169-0073, Japan.
Yumi OhbaDepartment of Food Safety, Tokyo Metropolitan Institute of Public Health, 3-24-1, Hyakunin-Cho, Shinjuku-Ku, Tokyo, 169-0073, Japan.
Momoka HayashiDepartment of Food Safety, Tokyo Metropolitan Institute of Public Health, 3-24-1, Hyakunin-Cho, Shinjuku-Ku, Tokyo, 169-0073, Japan.
Chieko NaganoDepartment of Food Safety, Tokyo Metropolitan Institute of Public Health, 3-24-1, Hyakunin-Cho, Shinjuku-Ku, Tokyo, 169-0073, Japan.
Kenji OtsukaDepartment of Food Safety, Tokyo Metropolitan Institute of Public Health, 3-24-1, Hyakunin-Cho, Shinjuku-Ku, Tokyo, 169-0073, Japan.
Junichi KamiieLaboratory of Veterinary Pathology, School of Veterinary Medicine, Azabu University, 1-17-71, Fuchinobe, Chuo-Ku, Sagamihara, Kanagawa, 252-5201, Japan.
Takeo SasamotoDepartment of Food Safety, Tokyo Metropolitan Institute of Public Health, 3-24-1, Hyakunin-Cho, Shinjuku-Ku, Tokyo, 169-0073, Japan.
Tokyo Metropolitan Institute of Public Health · JPAzabu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDetection of Clostridium perfringens enterotoxin (CPE) in human stool is critical evidence of food poisoning. However, processing patient-derived samples is difficult and very few methods exist to confirm the presence of CPE. In this study, a technique was developed using proteomic analysis to identify and quantify CPE in artificial gut fluid as an alternative.

methodsThe standard CPE was spiked into artificial gut fluids, and effective methods were developed by employing both a stable isotope-labelled internal standard peptide and liquid chromatography-tandem mass spectrometry (LC-MS/MS).

resultsProteotypic peptide EILDLAAATER formed by tryptic digestion was selected for quantitation of CPE. The peptide was identified using product ion spectra. Although the nontoxic peptides originating from CPE showed very low detectability in extraction and tryptic digestion, they could be detected with sufficient sensitivity using the method we developed. Based on a spiked recovery test at two concentrations (50 and 200 µg/kg), the recovery values were 85 and 78%, respectively. The relative standard deviations of repeatability and within-laboratory reproducibility were less than 8 and 11%, respectively. These standard deviations satisfied the criteria of the Japanese validation guidelines for residues (MHLW 2010, Director Notice, Syoku-An No. 1224-1). The limit of quantification (LOQ) was estimated to be 50 µg/kg. The combination of the product ion spectra and relative ion ratio supported CPE identification at the LOQ level.

conclusionsTo the best of our knowledge, this is the first report of proteomic analysis of CPE using LC-MS/MS. The method would greatly help in assessing CPE reliably.

Indexed as

ProteomicsTandem Mass SpectrometryChromatography, LiquidEnterotoxinsHumansIsotopesPeptidesReproducibility of Resultsenterotoxin, ClostridiumEnterotoxinsIsotopesPeptidesArtificial gut fluidClostridium perfringens enterotoxinLiquid chromatography–tandem mass spectrometryProteomic analysisStable isotope-labelled internal standard peptide

Identifiers

PMID36773219
OpenAlexW4320033044

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.